The Muha Corp's master case remains a troubling event, rocking the pharmaceutical world. Inquiries have shown a complex scheme involving purported misrepresentation and the unauthorized distribution of regulated medications. Many individuals, including executives and staff , confront serious charges related to kickbacks , falsified records, and a c